KMID : 0620920190510020014
|
|
Experimental & Molecular Medicine 2019 Volume.51 No. 2 p.14 ~ p.14
|
|
Mitochondrial superoxide dismutase 2 mediates ¥ã-irradiation-induced cancer cell invasion
|
|
Jung Chan-Hun
Kim Eun-Mi Song Jie-Young Park Jong-Kuk Um Hong-Duck
|
|
Abstract
|
|
|
Sublethal doses of ¥ã-rays promote cancer cell invasion by stimulating a signaling pathway that sequentially involves p53, sulfatase 2 (SULF2), ¥â-catenin, interleukin-6 (IL-6), signal transducer and activator of transcription 3 (STAT3), and Bcl-XL. Given that Bcl-XL can increase O2?? production by stimulating respiratory complex I, the possible role of mitochondrial reactive oxygen species (ROS) in ¥ã-irradiation-induced cell invasion was investigated. Indeed, ¥ã-irradiation promoted cell invasion by increasing mitochondrial ROS levels, which was prevented by metformin, an inhibitor of complex I. ¥ã-Irradiation-stimulated STAT3 increased the expression of superoxide dismutase 2 (SOD2), a mitochondrial enzyme that catalyzes the conversion of O2?? to hydrogen peroxide (H2O2). In contrast to O2??, H2O2 functions as a signaling molecule. ¥ã-Irradiation consistently stimulated the Src-dependent invasion pathway in a manner dependent on both complex I and SOD2. SOD2 was also essential for the invasion of un-irradiated cancer cells induced by upregulation of Bcl-XL, an intracellular oncogene, or extracellular factors, such as SULF2 and IL-6. Overall, these data suggested that SOD2 is critical for the malignant effects of radiotherapy and tumor progression through diverse endogenous factors.
|
|
KEYWORD
|
|
Cell invasion, Oncogenes
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|